03.05.14
Natick, Mass.-based Boston Scientific Corporation has elected Edward J. Ludwig to its board of directors. Ludwig fills a vacancy created by a company decision to raise the number of directors from 11 to 12.
Ludwig was formerly the CEO, president and chairman of the board of directors of medical technology company Becton, Dickinson and Company. Ludwig currently serves as lead director on Aetna Inc.’s board of directors and chairs its finance committee and is a member of the board of directors of Xylem Inc. He serves on the Columbia Business School board of overseers and is the vice chairman of the Hackensack University Medical Center Network Board of Trustees. Ludwig received a B.A. degree in economics and accounting from The College of the Holy Cross and an MBA from Columbia University in New York City, N.Y.
“Ed is an accomplished business leader and brings a wealth of experience and management insight to our Board,” said Board Chairman Pete Nicholas. “We look forward to his perspectives and insights, and are delighted to welcome him to the board.”
Boston Scientific’s medical products are aimed at meeting unmet patient needs and reducing the cost of healthcare.
Ludwig was formerly the CEO, president and chairman of the board of directors of medical technology company Becton, Dickinson and Company. Ludwig currently serves as lead director on Aetna Inc.’s board of directors and chairs its finance committee and is a member of the board of directors of Xylem Inc. He serves on the Columbia Business School board of overseers and is the vice chairman of the Hackensack University Medical Center Network Board of Trustees. Ludwig received a B.A. degree in economics and accounting from The College of the Holy Cross and an MBA from Columbia University in New York City, N.Y.
“Ed is an accomplished business leader and brings a wealth of experience and management insight to our Board,” said Board Chairman Pete Nicholas. “We look forward to his perspectives and insights, and are delighted to welcome him to the board.”
Boston Scientific’s medical products are aimed at meeting unmet patient needs and reducing the cost of healthcare.